Hutchmed China CFO Cheng is interim CEO as CEO Su takes health leave
(Alliance News) - Hutchmed China Ltd on Tuesday said Chief Executive Officer Weiguo Su will take a leave of absence for health reasons. Read More
Price | 260.00p on 12-09-2025 | at 18:30:06
---|---|
Change | 21.00p 8.79% |
Buy | 263.00p |
Sell | 258.00p |
Last Trade: | Buy 946.00 at 260.00p |
Day's Volume: | 133,927 |
Last Close: | 260.00p |
Open: | 243.00p |
ISIN: | KYG4672N1198 |
Day's Range | 243.00p - 266.00p |
52wk Range: | 187.50p - 336.00p |
Market Capitalisation: | £2.23b |
VWAP: | 259.7111p |
Shares in Issue: | 859.30m |
Sector: Medicine and Biotech
Listed In: FTSE AIM 100, FTSE AIM All-Share,
Hutchmed (HCM) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Buy* | 946 | 260.00p | Suspected BUY Trade |
16:35:15 - 12-Sep-25 |
Buy* | 1,900 | 263.0862p | Ordinary |
16:28:58 - 12-Sep-25 |
Sell* | 16 | 262.00p | Automatic Execution |
16:03:16 - 12-Sep-25 |
Sell* | 2,068 | 262.00p | Automatic Execution |
16:03:16 - 12-Sep-25 |
Buy* | 2,573 | 266.00p | Automatic Execution |
16:03:16 - 12-Sep-25 |
Buy* | 83 | 259.00p | Automatic Execution |
16:03:16 - 12-Sep-25 |
Buy* | 2,305 | 259.00p | Automatic Execution |
16:03:16 - 12-Sep-25 |
Buy* | 83 | 259.00p | Automatic Execution |
16:03:16 - 12-Sep-25 |
Buy* | 83 | 259.00p | Automatic Execution |
16:03:16 - 12-Sep-25 |
Sell* | 158 | 260.00p | Automatic Execution |
16:03:16 - 12-Sep-25 |
Hutchmed (HCM) Regulatory News |
||
Date | Source | Headline |
---|---|---|
12th Sep 2025 7:00 am | RNS-R | HUTCHMED to Present R&D Updates on October 31 2025 |
5th Sep 2025 7:00 am | RNS-R | HUTCHMED Highlights Data to be Presented at CSCO |
26th Aug 2025 7:00 am | RNS | Directorate Change |
20th Aug 2025 7:00 am | RNS-R | HUTCHMED Completes Enrollment of Phase III Trial |
7th Aug 2025 12:00 pm | RNS | 2025 Interim Results |
3rd Jul 2025 9:30 am | RNS | HUTCHMED to Announce 2025 Half-Year Results |
2nd Jul 2025 10:00 am | RNS | Update on Joint Corporate Brokers in London |
30th Jun 2025 9:30 am | RNS | China Approval based on Phase III SACHI Trial |
30th Jun 2025 9:30 am | RNS | Total Voting Rights |
30th Jun 2025 9:30 am | RNS | Blocklisting Six Monthly Return |